Business Daily Media

Business Marketing

.

Eisai: Fully Human Anti-TNFalpha Monoclonal Antibody HUMIRA Obtains Additional Approval

  • Written by ACN Newswire - Press Releases

Eisai: Fully Human Anti-TNFalpha Monoclonal Antibody HUMIRA Obtains Additional Approval

TOKYO, Sep 27, 2021 - (JCN Newswire) - AbbVie GK, Eisai Co., Ltd., and EA Pharma Co., Ltd announced today the additional approval for a high- dose regimen in adult patients with ulcerative colitis and for a new regimen in pediatric patients regarding fully Human Anti-TNFalpha Monoclonal Antibody HUMIRA (generic name, adalimumab [recombinant];...

Popular

Recognising the value and significance of cyber resilience

It’s common knowledge that businesses are frequently under threat from data breaches and cyberattacks. The advent of COVID-19 and a working from home model exposed large flaws in organisational cybersecurity, with controls o...

Could Gen Z be the solution to our nation’s labour shortage crisis?

Research Reveals the Future of Work for Australia's Gen Z WorkJam – the leading digital workplace for organisations with frontline employees – has provided insight into the working preferences of Australian Gen Zers in response...

Best Japanese gifts for the family

When in Japan, know about its gifting culture to touch the right chord. A little research about Japanese gifts presentable to a family can help in averting embarrassments. So, we bring you here the best Japanese gifts that y...

Virtual Office
Tomorrow Business Growth